Search Results - Victoria Delgado

  • Showing 1 - 3 results of 3
Refine Results
  1. 1
    2013 ESC GUIDELINES ON CARDIAC PACING AND CARDIAC RESYNCHRONIZATION THERAPY

    2013 ESC GUIDELINES ON CARDIAC PACING AND CARDIAC RESYNCHRONIZATION THERAPY by Michele Brignole, Angelo Auricchio, Gonzalo Baron-Esquivias, Pierre Bordachar, Giuseppe Boriani, Ole-A Breithardt, John Cleland, Jean-Claude Deharo, Victoria Delgado, Perry M. Elliott, Bulent Gorenek, Carsten W. Israel, Christophe Leclercq, Cecilia Linde, Lluís Mont, Luigi Padeletti, Richard Sutton, Panos E. Vardas

    Published 2014-04-01

    .

    Get full text
    Article

    Save to List
    Saved in:
  2. 2
    2019 ESC/EAS Guidelines for themanagement of dyslipidaemias: lipid modification to reduce cardiovascular risk

    2019 ESC/EAS Guidelines for themanagement of dyslipidaemias: lipid modification to reduce cardiovascular risk by Francois Mach, Colin Baigent, Alberico L. Catapano, Konstantinos C. Koskinas, Manuela Casula, Lina Badimon, M. John Chapman, Guy G. De Backer, Victoria Delgado, Brian A. Ference, Ian M. Graham, Alison Halliday, Ulf Landmesser, Borislava Mihaylova, Terje R. Pedersen, Gabriele Riccardi, Dimitrios J. Richter, Marc S. Sabatine, Marja-Riitta Taskinen, Lale Tokgozoglu, Olov Wiklund

    Published 2020-06-01

    The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS)

    Get full text
    Article

    Save to List
    Saved in:
  3. 3
    Initiating Empagliflozin and Sacubitril/Valsartan Early After Acute Myocardial Infarction: Mechanistic Study

    Initiating Empagliflozin and Sacubitril/Valsartan Early After Acute Myocardial Infarction: Mechanistic Study by Daina Martínez‐Falguera, Júlia Aranyó, Gemma Ferrer‐Curriu, Albert Teis, Elena Revuelta‐Lopez, Idoia Diaz‐Güemes, Marta Monguió‐Tortajada, Edgar Fadeuilhe, Oriol Rodríguez‐Leor, Francesc Poblador, Borja Montejo, Santiago Roura, Roger Villuendas, Axel Sarrias, Victor Bazan, Esther Jorge, Victoria Delgado, Francisco Rafael Jimenez‐Trinidad, Montserrat Rigol, Neus Martinez‐Micaelo, Núria Amigó, Antoni Bayes‐Genis, Felipe Bisbal, Carolina Gálvez‐Montón

    Published 2025-06-01

    Background Empagliflozin and sacubitril/valsartan are established in heart failure treatment, but their effects after myocardial infarction (MI) are less clear. This study evaluated early empagliflozin initiation, with or without sacubitril/valsartan, on post‐MI inflammation, oxidative stress, metab...

    Full description

    Get full text
    Article

    Save to List
    Saved in:

Search Tools: